Quick Look Market Closing Price:
At the close: Dow -0.58% to 13040. S&P -0.33% to 1386. Nasdaq -0.21% to 3036.
Treasurys: 30-year +0.22%. 10-yr +0.08%. 5-yr +0.02%.
Commodities: Crude -1.41% to $103.16. Gold -0.62% to $1640.85.
Currencies: Euro -0.07% vs. dollar. Yen +0.5%. Pound -0.61%.
After Hours News:
Cubist Pharmaceuticals (CBST): Q1 EPS of $0.82 beats by $0.19. Revenue of $211M (+30% Y/Y) in-line. Shares +3.2% AH
F5's (FFIV) FQ2: Company expects FQ3 revenue of $350M-$355M and EPS of $1.12-$1.14, compared with a consensus of $353.1M and $1.14. Strong demand is seen for both mid-range VIPRION 2400 switch and high-end VIPRION 4400. 404K shares repurchased during quarter. In spite of the in-line guidance, F5 is now up 5.9% AH, suggesting recent worries were more than baked in
Plexus (PLXS): FQ2 EPS of $0.56 beats by $0.02. Revenue of $573M (+1% Y/Y) beats by $7M. Shares -0.2% AH
For the latest updates on the stock market, visit,